STAT4pPOS cells were found in 12.6% of the CD8 T cells, 3.7% of the CD4 T cells, and 2.3% of the NK1.1 cells in the TME of a CT-2A tumor treated with rIL-12 (Figure S3K). This evidence concerns the gene CD4 and neoplasm.